United States
Premiumsupplier
Carfilzomib-d8 CAS NO.1537187-53-3
- Min.Order: 1 Gram
- Payment Terms: L/C
- Product Details
Keywords
- (αS)-α-[[2-(4-Morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyl-2-oxiranyl]carbonyl]butyl]-L-phenylalaninamide-d8
- (αS)-α-[(4-Morpholinylacetyl)amino]benzenebutanoyl-L-leucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyloxiranyl]ca
- 1537187-53-3
Quick Details
- ProName: Carfilzomib-d8
- CasNo: 1537187-53-3
- Molecular Formula: C40H49N5O7D8
- Application: arfilzomib-d8, is the labelled analogu...
- DeliveryTime: 7 days
- PackAge: inquiry
- Port: inquiry
- ProductionCapacity: 10 Kilogram/Month
- Purity: > 95%
- Storage: 10kg
- Transportation: inquiry
- LimitNum: 1 Gram
Superiority
BOC Sciences is committed to supplying cost-effective products and services. We provide Carfilzomib-d8. arfilzomib-d8, is the labelled analogue of Carfilzomib, which is a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma. More information please visit: www.bocsci.com/carfilzomib-d8-cas-1537187-53-3-item-468165.html
Details
BOC Sciences is committed to supplying cost-effective products and services. We provide Carfilzomib-d8. arfilzomib-d8, is the labelled analogue of Carfilzomib, which is a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma. More information please visit: www.bocsci.com/carfilzomib-d8-cas-1537187-53-3-item-468165.html